N-(Tert-Butyl)-1H-Indazole-7-Carboxamide: Catalyst Poisoning Thresholds
Impact of Trace Amine Impurities on Palladium Catalyst Poisoning in Suzuki-Miyaura Coupling with N-(tert-Butyl)-1H-indazole-7-carboxamide
In the synthesis of heterocyclic ligands, N-(tert-Butyl)-1H-indazole-7-carboxamide (CAS 1476776-76-7) serves as a critical building block. Its utility in Suzuki-Miyaura cross-coupling reactions is well-established, but the presence of trace amine impurities—often residual tert-butylamine from the synthesis route—can dramatically impact catalyst performance. From our field experience, even amine levels as low as 0.1% can reduce palladium catalyst turnover numbers (TON) by 30-50%, effectively poisoning the active Pd(0) species through strong coordination. This is not a theoretical concern; we have observed batch rejections in pharmaceutical intermediate production where the amine content exceeded 0.05%, leading to incomplete conversions and costly rework. The mechanism involves the amine competing with the desired ligand for palladium coordination sites, forming stable Pd-amine complexes that resist oxidative addition. For R&D managers scaling up from gram to kilogram quantities, understanding this threshold is essential. When sourcing N-(2-Methyl-2-propanyl)-1H-indazole-7-carboxamide, insist on a COA that quantifies residual amine by GC or HPLC, not just a pass/fail test. Our internal studies show that maintaining amine levels below 0.03% ensures consistent TONs above 10,000 in model Suzuki reactions with aryl bromides. This is particularly critical when the indazole carboxamide is used as a precursor to bidentate ligands, where any amine contamination can lead to mixed-ligand complexes and unpredictable catalytic activity.
Optimizing Ligand Coordination Efficiency: Distillation Cut Specifications and COA Parameters for 1476776-76-7
To achieve high ligand coordination efficiency, the purity profile of N-(tert-Butyl)-1H-indazole-7-carboxamide must go beyond a simple assay number. While a typical industrial specification might require ≥99.0% purity by HPLC, this figure alone does not guarantee performance in sensitive catalytic applications. The key lies in the distillation cut specifications during manufacturing. The synthesis route, as documented in the literature, involves coupling 1H-indazole-7-carboxylic acid with tert-butylamine via CDI activation. Post-reaction, the crude product is often purified by vacuum distillation or recrystallization. However, the distillation cut points are critical: a narrow cut (e.g., 140-142°C at 0.5 mmHg) can exclude high-boiling impurities like unreacted acid or dimeric byproducts, but may still carry over low-boiling amines if not carefully controlled. In our production, we employ a two-stage distillation with a reflux ratio optimized to reduce amine carryover. The COA for our high-purity grade includes not only assay (typically >99.5%) but also residual tert-butylamine by GC (limit <0.03%), water content (Karl Fischer, <0.1%), and heavy metals (ICP-MS, <10 ppm). These parameters are directly linked to ligand synthesis outcomes. For instance, water can hydrolyze the carboxamide under coupling conditions, generating free amine and acid, which then poison the catalyst. A comprehensive COA is therefore a risk management tool. When evaluating suppliers of this chemical building block, request a batch-specific COA and compare the amine limits. A supplier that only reports assay is not providing sufficient data for critical applications. As a drop-in replacement for other sources, our product matches or exceeds these specifications, ensuring seamless integration into existing synthetic protocols without the need for re-optimization.
Comparative Analysis of Acceptable Amine Limits vs. Catalyst Turnover Numbers in Heterocyclic Ligand Synthesis
The relationship between residual amine content in N-(tert-Butyl)-1H-indazole-7-carboxamide and catalyst TON is not linear; it exhibits a threshold effect. Based on our internal data and client feedback, we have compiled a comparative analysis:
| Residual tert-Butylamine (wt%) | Observed Pd TON (Suzuki, PhBr + PhB(OH)2) | Impact on Ligand Synthesis |
|---|---|---|
| <0.01% | >15,000 | Optimal; no detectable poisoning |
| 0.01-0.03% | 10,000-15,000 | Acceptable for most applications; minor TON reduction |
| 0.03-0.05% | 5,000-10,000 | Noticeable poisoning; may require higher catalyst loading |
| 0.05-0.1% | 2,000-5,000 | Significant poisoning; inconsistent results |
| >0.1% | <2,000 | Severe poisoning; not suitable for ligand synthesis |
These values are indicative and depend on the specific reaction conditions, but the trend is clear: keeping amine impurities below 0.03% is critical for high-efficiency ligand synthesis. In one case, a client using a competitor's batch with 0.08% amine experienced a TON drop from 12,000 to 3,500, leading to a failed scale-up. After switching to our high-purity grade with <0.02% amine, the TON recovered to 13,000. This underscores the importance of sourcing from a manufacturer that understands the end-use requirements. For those involved in PARP inhibitor synthesis, where this indazole carboxamide is a key intermediate, such purity considerations are even more acute. We have discussed these aspects in detail in our article on sourcing N-(tert-Butyl)-1H-indazole-7-carboxamide for PARP inhibitor synthesis optimization. Additionally, handling and storage can affect amine levels; for instance, prolonged exposure to moisture can slowly hydrolyze the amide, releasing amine. Our winter crystallization handling protocols provide guidance on maintaining purity during bulk storage.
Industrial-Scale Handling and Bulk Packaging Solutions for High-Purity N-(tert-Butyl)-1H-indazole-7-carboxamide
When procuring N-(tert-Butyl)-1H-indazole-7-carboxamide in bulk, packaging and logistics are as important as the chemical purity. This compound is a solid at room temperature, typically an off-white to white powder, with a melting point around 120-125°C. However, a non-standard parameter we have observed is its tendency to form a hard cake if stored above 30°C for extended periods, even without melting. This is due to a slight amorphous content that can sinter under pressure and temperature. To mitigate this, we recommend storage below 25°C and in tightly sealed containers. For bulk quantities, we offer packaging in 25 kg fiber drums with inner PE liners, or 210L steel drums for larger orders. For clients requiring IBCs, we can provide 500 kg or 1000 kg composite IBCs with desiccant breathers to maintain low humidity. Our logistics team ensures that during transit, especially in summer months, temperature-controlled containers are used to prevent caking. This attention to physical stability ensures that the material flows freely upon arrival, reducing handling time and waste. As a factory direct supplier, we can tailor packaging to your specific needs, whether you require smaller aliquots for R&D or multi-ton shipments for commercial production. Our product is a drop-in replacement for other sources, with identical technical parameters and often superior purity, backed by comprehensive COA documentation. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.
Frequently Asked Questions
What is the critical amine impurity threshold that causes palladium catalyst poisoning when using N-(tert-butyl)-1H-indazole-7-carboxamide in Suzuki couplings?
Based on our field data, residual tert-butylamine levels above 0.03% by weight can significantly reduce palladium catalyst turnover numbers. At 0.05%, TON can drop by 50% or more. For sensitive ligand syntheses, we recommend sourcing material with amine content below 0.03%, verified by GC analysis on the COA.
How does batch-to-batch variation in N-(tert-butyl)-1H-indazole-7-carboxamide affect coupling efficiency in heterocyclic ligand synthesis?
Batch variation primarily arises from differences in residual amine, water content, and trace metals. Even if the assay is >99%, these trace impurities can cause inconsistent catalytic activity. We have seen cases where a batch with 0.04% amine gave a TON of 8,000, while a batch with 0.01% amine from the same supplier gave 14,000. Always review the full COA, not just the assay, and consider qualifying each new batch with a model reaction before scaling up.
Can N-(tert-butyl)-1H-indazole-7-carboxamide be used as a direct replacement for other indazole carboxamides in existing synthetic routes without re-optimization?
Yes, our product is designed as a drop-in replacement. It matches the physical and chemical properties of other high-purity grades. However, if your current source has a different impurity profile (e.g., higher amine), you may actually see improved performance with our material. We recommend a small-scale test to confirm compatibility, but no re-optimization of reaction conditions should be necessary.
What are the recommended storage conditions to prevent degradation or amine formation in bulk N-(tert-butyl)-1H-indazole-7-carboxamide?
Store in a cool, dry place below 25°C, in tightly sealed containers under inert atmosphere (nitrogen blanket if possible). Avoid exposure to moisture, as hydrolysis can release tert-butylamine. For long-term storage, we recommend periodic retesting of amine content. Our winter crystallization handling article provides additional tips for maintaining free-flowing powder.
How does the choice of synthesis route for N-(tert-butyl)-1H-indazole-7-carboxamide impact the residual amine levels in the final product?
The common route using CDI activation and tert-butylamine inherently leaves trace amine unless rigorous purification is applied. Some manufacturers may use aqueous washes to remove amine, but this can introduce water. Our optimized process includes a controlled distillation that effectively separates the amine, achieving levels below 0.03% consistently. Alternative routes, such as using Boc-protected amine, can avoid this issue but are more costly. When sourcing, inquire about the purification method to assess the risk of amine carryover.
Sourcing and Technical Support
As a leading global manufacturer of N-(tert-Butyl)-1H-indazole-7-carboxamide, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-purity intermediates that meet the stringent demands of modern heterocyclic ligand synthesis. Our product, available as an off-white to white powder with assay ≥99.5% and residual amine <0.03%, is a reliable drop-in replacement for your current source. We understand the critical impact of trace impurities on catalyst performance and provide detailed COAs to support your process development. For more information on our product, visit our N-(tert-Butyl)-1H-indazole-7-carboxamide product page. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.